Whats new
Whats new.
CLSA - Immutep: Defining year. Cash-runway through late stage head & neck readout and Lung Ph3 start. Retain Buy, A$1.25 tgt (Andrew Paine)
March 8th 2023
For a copy of this analyst report please contact your CLSA advisor
Whats new
March 8th 2023
For a copy of this analyst report please contact your CLSA advisor